2024 ICD-10-CM Procedure Code 3E0DX05

Introduction of Other Antineoplastic into Mouth and Pharynx, External Approach

ICD-10-PCS Code:: 3E0DX05
ICD-10-PCS Code for:: Introduce Oth Antineoplastic in Mouth/Phar, Extern
Is Billable?: Yes - Valid for Submission
Code Navigator:

3E0DX05 is a billable procedure code used to specify the performance of introduction of other antineoplastic into mouth and pharynx, external approach. The code is valid for the year 2024 for the submission of HIPAA-covered transactions.

Table of Contents

Code Information
PCS Table
Replaced Code
Clinical Classification
Convert to ICD-9-PCS
Other Similar Codes

3E0DX05 PCS Table

In an PCS table each code is represented by up seven alphanumeric characters, with each character in the table respresenting different aspects of the procedure. In the table provided below, each row represents an individual character and includes information about the character's position, designation, label, and procedure notes. For this PCS table the procedure code is in the administration section and is part of the physiological systems and anatomical regions body system, classified under introduction operation. The applicable bodysystem/region for this procedure code is mouth and pharynx.

Position	Designation	Character	Label	Procedures Notes
1	Section	3	Administration
2	Body System	E	Physiological Systems and Anatomical Regions
3	Operation	0	Introduction	Involves: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
4	BodySystem/Region	D	Mouth and Pharynx
5	Approach	X	External	Involves: Procedures performed directly on the skin or mucous membrane and procedures performed indirectly by the application of external force through the skin or mucous membrane
6	Substance	0	Antineoplastic
7	Qualifier	5	Other Antineoplastic

Replaced Code

3E0DX05 was replaced in the 2024 ICD-10-PCS code set with the code(s):

XW0DXJ5 - Introduce Apalutamide in Mouth/Phar, Extern, New Tech 5
XW0DXJ5 - Introduce Apalutamide in Mouth/Phar, Extern, New Tech 5
XW0DXJ5 - Introduce Apalutamide in Mouth/Phar, Extern, New Tech 5
XW0DXJ5 - Introduce Apalutamide in Mouth/Phar, Extern, New Tech 5
XW0DXJ5 - Introduce Apalutamide in Mouth/Phar, Extern, New Tech 5
XW0DXJ9 - Introduce Quizartinib in Mouth/Phar, Extern, New Tech 9
XW0DXL5 - Introduce Erdafitinib in Mouth/Phar, Extern, New Tech 5
XW0DXL5 - Introduce Erdafitinib in Mouth/Phar, Extern, New Tech 5
XW0DXL5 - Introduce Erdafitinib in Mouth/Phar, Extern, New Tech 5
XW0DXL5 - Introduce Erdafitinib in Mouth/Phar, Extern, New Tech 5
XW0DXL5 - Introduce Erdafitinib in Mouth/Phar, Extern, New Tech 5
XW0DXR5 - Introduce Venetoclax in Mouth/Phar, Extern, New Tech 5
XW0DXR5 - Introduce Venetoclax in Mouth/Phar, Extern, New Tech 5
XW0DXR5 - Introduce Venetoclax in Mouth/Phar, Extern, New Tech 5
XW0DXR5 - Introduce Venetoclax in Mouth/Phar, Extern, New Tech 5
XW0DXR5 - Introduce Venetoclax in Mouth/Phar, Extern, New Tech 5
XW0DXV5 - Introduce Gilteritinib in Mouth/Phar, Extern, New Tech 5
XW0DXV5 - Introduce Gilteritinib in Mouth/Phar, Extern, New Tech 5
XW0DXV5 - Introduce Gilteritinib in Mouth/Phar, Extern, New Tech 5
XW0DXV5 - Introduce Gilteritinib in Mouth/Phar, Extern, New Tech 5
XW0DXV5 - Introduce Gilteritinib in Mouth/Phar, Extern, New Tech 5

Clinical Classification

Clinical Category is Chemotherapy
CCSR Category Code: ADM012
Clinical Domain is Administration of Therapeutic Substances - ADM contains 22 categories that include procedures associated with the administration of therapeutic substances, such as the transfusion of blood and blood products, vaccinations, and chemotherapy.

Convert to ICD-9-PCS

The following crosswalk between ICD-10-PCS to ICD-9-PCS is based based on the General Equivalence Mappings (GEMS) information:

ICD-9-PCS: 9925 (Approximate Flag) Approximate Flag
The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.

Other ICD-10-PCS Codes Used for Introduction Mouth and Pharynx

3E0D304 Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Percutaneous Approach
3E0D305 Introduction of Other Antineoplastic into Mouth and Pharynx, Percutaneous Approach
3E0D30M Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach
3E0D328 Introduction of Oxazolidinones into Mouth and Pharynx, Percutaneous Approach
3E0D329 Introduction of Other Anti-infective into Mouth and Pharynx, Percutaneous Approach
3E0D33Z Introduction of Anti-inflammatory into Mouth and Pharynx, Percutaneous Approach
3E0D34Z Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Percutaneous Approach
3E0D36Z Introduction of Nutritional Substance into Mouth and Pharynx, Percutaneous Approach
3E0D37Z Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Percutaneous Approach
3E0D3BZ Introduction of Anesthetic Agent into Mouth and Pharynx, Percutaneous Approach
3E0D3GC Introduction of Other Therapeutic Substance into Mouth and Pharynx, Percutaneous Approach
3E0D3HZ Introduction of Radioactive Substance into Mouth and Pharynx, Percutaneous Approach
3E0D3KZ Introduction of Other Diagnostic Substance into Mouth and Pharynx, Percutaneous Approach
3E0D3NZ Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Percutaneous Approach
3E0D3RZ Introduction of Antiarrhythmic into Mouth and Pharynx, Percutaneous Approach
3E0D3TZ Introduction of Destructive Agent into Mouth and Pharynx, Percutaneous Approach
3E0D704 Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D705 Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D70M Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D728 Introduction of Oxazolidinones into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D729 Introduction of Other Anti-infective into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D73Z Introduction of Anti-inflammatory into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D74Z Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D76Z Introduction of Nutritional Substance into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D77Z Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D7BZ Introduction of Anesthetic Agent into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D7GC Introduction of Other Therapeutic Substance into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D7HZ Introduction of Radioactive Substance into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D7KZ Introduction of Other Diagnostic Substance into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D7NZ Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D7RZ Introduction of Antiarrhythmic into Mouth and Pharynx, Via Natural or Artificial Opening
3E0D7TZ Introduction of Destructive Agent into Mouth and Pharynx, Via Natural or Artificial Opening
3E0DX04 Introduction of Liquid Brachytherapy Radioisotope into Mouth and Pharynx, External Approach
3E0DX0M Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach
3E0DX28 Introduction of Oxazolidinones into Mouth and Pharynx, External Approach
3E0DX29 Introduction of Other Anti-infective into Mouth and Pharynx, External Approach
3E0DX3Z Introduction of Anti-inflammatory into Mouth and Pharynx, External Approach
3E0DX4Z Introduction of Serum, Toxoid and Vaccine into Mouth and Pharynx, External Approach
3E0DX6Z Introduction of Nutritional Substance into Mouth and Pharynx, External Approach
3E0DX7Z Introduction of Electrolytic and Water Balance Substance into Mouth and Pharynx, External Approach
3E0DXBZ Introduction of Anesthetic Agent into Mouth and Pharynx, External Approach
3E0DXGC Introduction of Other Therapeutic Substance into Mouth and Pharynx, External Approach
3E0DXHZ Introduction of Radioactive Substance into Mouth and Pharynx, External Approach
3E0DXKZ Introduction of Other Diagnostic Substance into Mouth and Pharynx, External Approach
3E0DXNZ Introduction of Analgesics, Hypnotics, Sedatives into Mouth and Pharynx, External Approach
3E0DXRZ Introduction of Antiarrhythmic into Mouth and Pharynx, External Approach
3E0DXTZ Introduction of Destructive Agent into Mouth and Pharynx, External Approach

What is ICD-10-PCS?

The ICD-10 Procedure Coding System (ICD-10-PCS) is a catalog of procedural codes used by medical professionals for hospital inpatient healthcare settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates. The 2024 ICD-10-PCS codes are to be used for discharges occurring from October 1, 2023 through September 30, 2024.

Each ICD-10-PCS code has a structure of seven alphanumeric characters and contains no decimals. The first character defines the major "section". Depending on the "section" the second through seventh characters mean different things.